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Background: Ticks are hematophageous arthropods that transmit a wide spectrum of pathogens to human and
animals. The ability of an acaricidal product to kill ticks quickly provides an important added benefit, especially as
protecting dogs from tick bites remains the best preventive measure against tick-borne diseases. The speed of kill
of afoxolaner in a novel soft chewable formulation (NexGardTM) against induced infestations with Ixodes ricinus adult
ticks was evaluated during a full-month negative controlled and blinded study following a single oral administration.
Methods: 12 healthy beagle dogs were included and randomly allocated to 2 groups of six dogs each. One Group
was a negative control while the other group was treated with an oral formulation of afoxolaner on Day 0. Tick
infestations with 40 (±5) female and 10 male adult unfed I. ricinus were performed on Days −1, 7, 14, 21 and 28. To
evaluate immediate efficacy, the number of live ticks were thumb counted at 12 and 24 hours post treatment. To
evaluate the persistent speed of kill following further infestations, ticks were thumb counted 12 and 24 hours post
infestations. Ticks were removed 24 hours post treatment or infestation.
Results: Afoxolaner starts to kill the pre-existing tick infestations rapidly with an immediate efficacy of 93.4% and 100%
respectively at 12 h and 24 h post treatment. The persistent speed of kill of afoxolaner was significant (p < 0,05), as
compared with untreated controls, at 12 hours after infestations at D7 and D21. Efficacy at 12 h was 76.6%, 41.9%,
36.9% and 38.5% at D7, D14, D21 and D28 respectively. Efficacy at 24 h ranged from 91% to 100% for the entire month.
Conclusions: This study demonstrated that besides the excellent acaricidal efficacy of afoxolaner after single oral
administration, the product has a rapid speed of kill against one of the most important European tick species and
controlled the weekly re-infestations for 28 days post treatment.
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Ticks are major ectoparasites of humans and animals. In
addition to their direct pathogenic role, they are also known
as vectors for a wide range of pathogenic microorganisms.
Ixodes ricinus is the most common tick species occurring
in Europe. It is the vector of various vector borne
pathogens including Borrelia burgdorferi (the agent of
Lyme disease), Anaplasma phagocytophilum (the agent
of granulocytic ehrlichiosis) or the virus responsible of* Correspondence: lenaig.halos@merial.com
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unless otherwise stated.tick-borne Encephalitis [1,2]. The geographic distribution
of the tick species is expanding in Europe [3] as a result of
climate changes or increasing movements of people
travelling abroad with their pets [4] and it represents
a major threat for human and animal health. As an
example, a recent study demonstrated that almost
60% of the ticks collected from humans in Italy were
I. ricinus ticks and that 21% of them were carrying at
least one pathogenic microorganism [5].
Canine tick-borne diseases are among the most prevalent
infectious diseases in the dog population in Europe [6]. The
main pathogens transmitted to dogs by I. ricinus ticks aretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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a few cases of Ixodes-borne viral diseases (TBE-virus,
Louping-ill virus) have also been described in dogs in
Europe [1]. Protecting dogs from tick bites remains a
primary preventive measure against those diseases.
Numerous acaricides have been developed for the
protection of dogs against ticks which include topical
solutions as spray, collars, or spot-on and, more recently,
oral formulations. Due to delayed transmission of many
tick-borne pathogens [7], a rapid onset of action of an acari-
cide is likely to have an impact on pathogen transmission
[8] and this feature brings an important added value to any
acaricidal solution. According to the standard determined
by pharmaceutical regulation worldwide, an anti-tick
product for dogs should give a minimal activity of
90% acaricidal efficacy, characterized by a reduction
in tick counts 48 h after treatment and the prevention of
re-infestation [9]. Faster acting acaricidal activity, i.e.
within the first hours post treatment or subsequent
infestation, is interesting to evaluate, especially from a
perspective of reduction of the risk of diseases transmission.
Orally administrated afoxolaner has demonstrated a
persistent efficacy against the main species of ticks
infesting dogs with >90% efficacy 48 hours post treatment
or infestation for one month after treatment against
I. ricinus, I. scapularis, Dermacentor reticulatus, D.
variabilis, Rhipicephalus sanguineus, Haemaphysalis
longicornis [10-14].
The objective of the present study was to assess imme-
diate efficacy of this novel oral formulation of afoxolaner
(NexGardTM, Merial) against an existing I. ricinus tick
infestation and its persistent preventive speed of kill
against subsequent infestations with I. ricinus ticks
within the first hours post- treatment or subsequent
re-infestation.
Methods
The study was conducted using a negative controlled
and blinded design, with dogs randomly allocated to
two groups of 6 dogs (treated and control). Prior to
treatment, all dogs underwent a physical examination
conducted by a veterinarian and daily health observations
by trained personnel to ensure that they were healthy. To
detect the presence or absence of any treatment-related
or unrelated health abnormality or adverse event,
health observations were conducted at hourly intervals for
four hours after treatment and daily thereafter throughout
all studies.
Study design
The study was designed in accordance with the
World Association for the Advancement of Veterinary
Parasitology (W.A.A.V.P.) guidelines for evaluating the
efficacy of parasiticides for the treatment, preventionand control of flea and tick infestation on dogs and
cats [15]. All animals were managed similarly, with due
regard for their well-being and in compliance with Merial
Ethics Committee, other local applicable regulations and
requirements (reference numbers of the authorization:
APS 10-09-0005 and 1423). The study was conducted
in accordance with the International Cooperation on
Harmonization of Technical Requirements for Registration
of Veterinary Medicinal Products (VICH) [16].Animals
Fourteen Beagle dogs were allocated based on pretreatment
tick infestation. The 2 dogs with the lowest live attached
tick counts were not allocated and were removed from the
study. Dogs were older than 4 months, and body weight
ranked from 6.6 kg to 10.7 kg on Day −2. They had not
been treated with ectoparasiticides (either topical or
systemic) within 3 months before the start of the study.Ticks
Ticks were from a German laboratory-maintained popu-
lation that had been established from I. ricinus ticks
collected in the field in Europe. These ticks were from a
strain not known to be resistant to any ectoparasiticide.Treatment
On Day 0, dogs from Group 2 were treated with
NexGardTM chewable at the commercial dose. Dogs
from Group 1 were not treated. Chewable tablets were
manually administered into the back of the mouth. No
product was rejected during the treatment administration.
Personnel involved with evaluation of efficacy were blinded
as to treatment.Tick infestations and counts
On Days −1, 7, 14, 21 and 28, all dogs were infested with
40 (±5) females and 10 males adult unfed I. ricinus.
On Day 0, the immediate efficacy was evaluated by
thumb-counting ticks on dogs 12 hours post-treatment.
Final count and removal of ticks was performed 24 hours
post-treatment.
On Days 7, 14, 21 and 28, ticks were thumb counted
12 hours post-infestation and were counted and removed
24 hours post-infestation for the evaluation of the persist-
ent speed of kill. An infestation rate of >25% in control
group was considered to be an adequate infestation.
These counts were performed by methodical exam-
ination of the whole body, parting and feeling through
the dog’s hair with the finger tips, with further visual
confirmation of the tick’s presence. Ticks were categorised
as free or attached, live or dead, as described by
Marchiondo et al. [15].
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The live female tick counts (attached or free) were
transformed to the natural logarithm of (count + 1),
for calculation of geometric means by treatment
group at each time point. The treatment group was
listed as the fixed effect and blocks were listed as the
random effect. Percent efficacy of each treated group
with respect to the control group was calculated using the
formula: [(C - T) / C] × 100 where C = geometric mean for
the control group and T = geometric mean for the respect-
ive treated group. The log-counts of the treated group were
compared to the log-counts of the untreated control group
using a non-parametric test, the Wilcoxon rank sum test,
at each time for the live ticks. The testing was two-sided
and used a significance level of 5%. All analyses were
performed using the R language version 2.15.3 [17].
Results
Treated dogs did not show any adverse effect related to
treatment.
The geometric mean number of live female ticks ranged
between 14.5 and 24.4 for dogs in the control Group,
corresponding to a minimum retention rate of 37%,
sufficient to make a valid assessment of tick efficacy [15].
The immediate efficacy of afoxolaner against existing tick
infestations reached 93.4% within 12 hours after treatment
and was complete (100%) 24 hours post-treatment (Table 1).
The persistent speed of kill showed a significant reduc-
tion in tick counts 12 hours post-infestation when
compared to the controls at D7 and D21 (p < 0.05), with
efficacy of 76.6%, 41.9%, 36.9% and 38.5% respectively at
D7, D14, D21 and D28. The efficacy at 24 hours
post-infestation ranged from 91.2 to 100% for each
challenge throughout the whole month.
Discussion
When orally administered, afoxolaner is systematically
distributed in the body of the treated dog and plasmaTable 1 Geometric means of live female tick counts at the sch
infestations
Days of tick count Day 0 Day 7
Hours of tick counts1 12 h 24 h 12 h 24
Number of ticks2
14.5 16.4 20.8 24.Untreated Control Group
Number of ticks2
1.0 0.0 4.9 0.0Treated Group (NexGardTM)
% Efficacy3 93.4** 100.0** 76.6* 100.
1Hours of tick counts are indicated either post-treatment on D0 or post-infestation
2Geometric means tick counts.
3Based on Geometric means.
Treated Group differed statistically significantly from the untreated control Group w
*(p < 0.05).
**(p < 0.01).concentrations peak quickly within 2 to 6 hours [18].
The immediate efficacy against existing tick infestation
is therefore rapid and this is illustrated by the onset of
action on experimental infestation with I. ricinus ticks
which reached >93.4% efficacy 12 hours post-treatment
and 100% 24 hours post-treatment.
Attachment and ingestion of material containing
afoxolaner is likely required to affect ticks applied after
treatment. Although ticks typically start to effectively take
blood only 24 hours post-attachment, with the first hours
being dedicated to the attachment process [19], fluid
exchanges between the tick and the host still occur during
the very first phase of attachment, as ticks will ingest a
limited quantity of plasma during this phase [20]. The
present study suggests that the quantity of afoxolaner in
contact with the tick during this fluid exchange is enough
to initiate the killing of the ticks. The onset of action is
observed within 12 hours and the efficacy is completed at
24 hours post-infestation for the whole month following
NexGardTM administration.
These results corroborate the hypothesis that afoxolaner
rapidly kills ticks as suggested in a recent study that dem-
onstrated the ability of orally administrated afoxolaner to
block the transmission of Babesia canis by Dermacentor
reticulatus ticks to dogs with 100% of protection of the
treated dogs [21]. The level of protection against disease
transmission depends on the time required for the trans-
mission of the responsible pathogen: it is probably lower
against pathogens in which transmission starts earlier, as
soon as salivation begins, within a few minutes or hours of
attachment such as it has been demonstrated for viruses
[22] or suggested for Rickettsia conorii [23], but is expected
to be high against pathogens requiring more than
24 hours of attachment to be transmitted such as Borrelia
burgdorferi [24] or Anaplasma phagocytophilum [25].
Dynamics and pattern of seasonal activity of ticks have
been shown to be changing dramatically in Europe due
to both climate changes and non-climatic factors [3].eduled hours following treatment and further induced
Day 14 Day 21 Day 28
h 12 h 24 h 12 h 24 h 12 h 24 h
4 22.4 21.8 19.1 21.2 19.9 19.3
13.0 0.1 12.1 0.7 12.2 1.7
0** 41.9 99.4** 36.9* 96.6* 38.5 91.2**
on days 7, 14, 21, 28.
ith:
Halos et al. Parasites & Vectors 2014, 7:452 Page 4 of 4
http://www.parasitesandvectors.com/content/7/1/452The risk of I. ricinus tick infestation and tick-borne
disease transmission is not limited to Spring and Autumn
[26]. It can even be very high in winter in some areas of
Southern Europe [27]. For an optimal protection of the
dogs, the period of treatment has to be adapted to each
epidemiological situation.
Conclusion
In addition to its demonstrated acaricidal efficacy, afoxola-
ner, administrated orally in NexGardTM formulation, has a
quick onset of action against I. ricinus, allowing a rapid
elimination of the existing infestations and preventing the
establishment of further infestations for a month.
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